Metraipolis › archive › dc_afdb92698697
Signal mining and analysis of influencing factors for adverse events of Nivolumab and Cetuximab in the treatment of head and neck cancer based on the US FAERS… — Europe PMC PMID:41235256
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41235256
- DOI
- 10.3389/fimmu.2025.1658535
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:42:10.963Z
- SHA-256 of the archived text
011dbacbbac4e1081d828d89a9785829b30c63da697d6fa6ca3b8e6ae34caced- Stable URL of this page
https://metraipolis.com/documento/dc_afdb92698697
How to cite
Signal mining and analysis of influencing factors for adverse events of Nivolumab and Cetuximab in the treatment of head and neck cancer based on the US FAERS… — Europe PMC PMID:41235256 — Europe PMC (en), https://europepmc.org/article/MED/41235256 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afdb92698697 (Metraipolis archive dc_afdb92698697, sha256 011dbacbbac4e1081d828d89a9785829b30c63da697d6fa6ca3b8e6ae34caced)
BibTeX
@misc{dcafdb92698697,
title = {Signal mining and analysis of influencing factors for adverse events of Nivolumab and Cetuximab in the treatment of head and neck cancer based on the US FAERS… — Europe PMC PMID:41235256},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41235256},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afdb92698697; sha256 011dbacbbac4e1081d828d89a9785829b30c63da697d6fa6ca3b8e6ae34caced},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41235256. Agents can read the archived copy with the MCP tool read_document.